Phenomics Australia Communications and Outreach Coordinator, Dr Marina Trigueros recently had the privilege of touring a leading research hub at the Australian Institute for Bioengineering and Nanotechnology (AIBN) at the University of Queensland (UQ), where our high-skilled staff showcased state-of-the-art equipment and groundbreaking advancements.
We are grateful for the opportunity to witness the transformative work happening in our own backyard and are excited to share this journey with our community.
The immersive tour guided by the Phenomics Australia UQ in-vitro Genome Engineering and Disease Modelling Service (IGEDMS)’s expert team led by Phenomics Australia Scientific Director Prof. Ernst Wolvetang offered a firsthand look into cutting-edge laboratories and the latest technological marvels, providing a glimpse into the solutions that they offer to assist researchers and the biopharmaceutical industry to use pluripotent stem cells to study and test the impact of genetic mutations on disease.
While we were there, we had the fantastic opportunity to also tour the Australian Organoid Facility where their expert team revealed advanced facilities featuring state-of-the-art technology and instrumentation, providing a sneak peek into the forthcoming realm of scientific breakthroughs.
Our sincere thanks to Dr Madiha (Maddy) Yunus manager of the IGEDMS and Dr Nathan Gödde manager of the Australian Organoid Facility (AOF) for their dedication and passion, making this visit an unforgettable experience. We anticipate the impact of the hub’s innovative work and look forward to sharing more about our insights with our community.
Phenomics Australia provides a national centre of expertise and service provision to deploy a more comprehensive and sophisticated range of in vitro Genome Engineering and Disease Modelling capabilities to understand the functional consequences of DNA sequence variation in the human genome for health and disease while maintaining the expertise for in vivo disease modelling and genome engineering. To meet the high demand for adaptable and scalable disease-modelling platforms for improved diagnosis, Precision Medicine for genetic disorders, and therapeutic development by both academia and the biopharmaceutical industry, Phenomics Australia offers In Vitro services through a collaborative consortium of ten laboratories and facilities across Australia, operating at ANU (ANU Centre for Therapeutic Discovery), Perkins (Translational Cancer Research Program in Oncology), Monash (Monash Organoid Program & Monash Genome Modification Platform), MCRI (iPSC derivation & Gene Editing Facility), Peter Mac (Victorian Centre for Functional Genomics), UMelb (Centre for Stem Cell Systems & Stem Cell Disease Modelling Laboratory), UQ (In vitro Genome Engineering and Disease Modelling Service), and VCCRI (Stem Cell Production Facility iPSC Reprogramming Service)
